Scorpion Anti-venum

In August of 2011, the US Food and Drug Administration approved Anascorp®, the first specific treatment for scorpion stings by Centruroides scorpions in the United States.  Anascorp®, Centruroides (Scorpion) Immune F(ab’)2 (Equine) Injection, is made from the plasma of  horses immunized with scorpion venom.  The venom-specifi

High Dose Influenza Vaccine

This 2010-2011 flu season offers the “high-dose” influenza vaccine to older patients.  It is indicated in patients > 65 years of age for seasonal influenza prophylaxis.  There are two schools of thought when it comes to the reasoning behind the high dose vaccine.  The first is that it is thought that a patient’s  immune system weaken as he/she grows older and are therefore not able to mount an immunologic response to an infection as well as a young patient.  The second thought is that aging also decreases the body’s ability to build a stro

Pharmacy Contributions in Haiti Relief Efforts by Allison M Mann PharmD

Clinical Pearl: January 22, 2009 – Pharmacy Contributions in Haiti Relief Efforts
As I am sure everyone is aware, last week the island nation of Haiti was hit by a devastating earth quake.  This natural event would be devastating for any country, but is an especially large blow to Haiti, the poorest nation in the western hemisphere.  On Saturday, Jan 16th,

Understanding MELD by Sue Johanson, PharmD Candidate

 Please download the slides before viewing

Steroids: A Review by Rahel Woldo,PharmD

GLUCOCORTICOSTEROID - A review Introduction: It is estimated that more than 5 million patients are treated with glucocorticosteroids annually. The anti-inflammatory and immunosuppressive effects of steroids have been exploited in the treatment of diseases such as; bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, collagen vascular diseases, chronic active hepatitis and certain forms of nephritides. In many instances the use of glucocorticosteroids is for short-term purposes.

Syndicate content